Thomson Reuters Corp

TRI remains in a pronounced Stage 4 decline with lower highs and lows across timeframes. Medium-term bias is bearish as price trades below the 9/21 EMAs, 50 DMA, and 200 DMA with confirmed support failure. Recent rebound attempts have been rejected at the declining EMAs, providing a clean sell entry at resistance. Neutral overbought/oversold context offers no timing tailwind, reinforcing execution now.

• ↑Q1 2026 organic revenue grew 8% to $1.86 B, led by legal segment.
• ↑Adjusted EBITDA climbed to $881 M with a 42.2% margin.
• ↓Negative earnings yield indicates valuation pressure.